Depression and anxiety
- PMID: 25370281
- DOI: 10.5694/mja12.10628
Depression and anxiety
Abstract
Comorbid depression and anxiety disorders occur in up to 25% of general practice patients. About 85% of patients with depression have significant anxiety, and 90% of patients with anxiety disorder have depression. Symptomatology may initially seem vague and non-specific. A careful history and examination with relevant investigations should be used to make the diagnosis. Once the diagnosis is made, rating scales may identify illness severity and help in monitoring treatment progress. Both the depression disorder and the specific anxiety disorder require appropriate treatment. Psychological therapies, such as cognitive behaviour therapy, and antidepressants, occasionally augmented with antipsychotics, have proven benefit for treating both depression and anxiety. Benzodiazepines may help alleviate insomnia and anxiety but not depression. They have dependency and withdrawal issues for some people, and may increase the risk of falls in older people. Despite the availability of treatments, 40% of patients with depression or anxiety do not seek treatment, and of those who do, less than half are offered beneficial treatment.
Similar articles
-
Effectiveness of mindfulness-based cognitive therapy for comorbid depression and anxiety in pregnancy: a randomized controlled trial.Arch Womens Ment Health. 2020 Apr;23(2):207-214. doi: 10.1007/s00737-019-00962-8. Epub 2019 Apr 13. Arch Womens Ment Health. 2020. PMID: 30982086 Clinical Trial.
-
[Anxiety and depressive disorders in 4,425 long term benzodiazepine users in general practice].Encephale. 2007 Jan-Feb;33(1):32-8. doi: 10.1016/s0013-7006(07)91556-0. Encephale. 2007. PMID: 17457292 French.
-
Randomized controlled trial of group cognitive behavioral therapy compared to a discussion group for co-morbid anxiety and depression in older adults.Psychol Med. 2016 Mar;46(4):785-95. doi: 10.1017/S0033291715002251. Epub 2015 Oct 26. Psychol Med. 2016. PMID: 26498268 Clinical Trial.
-
Comorbidity of depression and anxiety in the elderly.Curr Psychiatry Rep. 2003 May;5(1):62-7. doi: 10.1007/s11920-003-0011-7. Curr Psychiatry Rep. 2003. PMID: 12686004 Review.
-
Comorbidity of anxiety and depressive disorders: issues in conceptualization, assessment, and treatment.J Psychiatr Pract. 2004 Sep;10(5):296-306. doi: 10.1097/00131746-200409000-00003. J Psychiatr Pract. 2004. PMID: 15361744 Review.
Cited by
-
Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders.Front Syst Neurosci. 2022 Oct 5;16:963691. doi: 10.3389/fnsys.2022.963691. eCollection 2022. Front Syst Neurosci. 2022. PMID: 36276608 Free PMC article. Review.
-
The impact of COVID-19 on the mental health of pregnant women in Shanghai, China.Front Public Health. 2022 Oct 6;10:938156. doi: 10.3389/fpubh.2022.938156. eCollection 2022. Front Public Health. 2022. PMID: 36276386 Free PMC article.
-
Anxiety in heart failure patients and its association with socio-demographic and clinical characteristics: a cross-sectional study.Porto Biomed J. 2022 Sep 9;7(4):e177. doi: 10.1097/j.pbj.0000000000000177. eCollection 2022 Jul-Aug. Porto Biomed J. 2022. PMID: 36186120 Free PMC article.
-
Global hotspots and prospects of perimenopausal depression: A bibliometric analysis via CiteSpace.Front Psychiatry. 2022 Sep 10;13:968629. doi: 10.3389/fpsyt.2022.968629. eCollection 2022. Front Psychiatry. 2022. PMID: 36164290 Free PMC article. Review.
-
Symptoms of anxiety and depression predicting fall-related outcomes among older Americans: a longitudinal study.BMC Geriatr. 2022 Sep 14;22(1):749. doi: 10.1186/s12877-022-03406-8. BMC Geriatr. 2022. PMID: 36100852 Free PMC article.
